Volume 2 Issue 1
Jan.  2011
Turn off MathJax
Article Contents
Jian-zhou LIU, Qi MIAO, Xing-rong LIU, Heng ZHANG, Chao-ji ZHANG, Guo-tao MA, Li-hua CAO, Chao WANG, Xiao-feng LI, Hai-bo DENG, Guang-jun CHEN, Wei LIU, Yu-guang HUANG, Yan SHI, Xiao-ting WANG, Da-wei LIU, Bao-tong ZHOU, Huan-ling WANG. Short- and Long-term Outcomes of Surgical Treatment of Active Infective Endocarditis[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(1): 28-32. doi: 10.3969/j.issn.1674-9081.2011.01.006
Citation: Jian-zhou LIU, Qi MIAO, Xing-rong LIU, Heng ZHANG, Chao-ji ZHANG, Guo-tao MA, Li-hua CAO, Chao WANG, Xiao-feng LI, Hai-bo DENG, Guang-jun CHEN, Wei LIU, Yu-guang HUANG, Yan SHI, Xiao-ting WANG, Da-wei LIU, Bao-tong ZHOU, Huan-ling WANG. Short- and Long-term Outcomes of Surgical Treatment of Active Infective Endocarditis[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(1): 28-32. doi: 10.3969/j.issn.1674-9081.2011.01.006

Short- and Long-term Outcomes of Surgical Treatment of Active Infective Endocarditis

doi: 10.3969/j.issn.1674-9081.2011.01.006
More Information
  • Corresponding author: MIAO Qi   Tel:010-65296067, E-mail:miaoqipumc@hotmail.com
  • Received Date: 2010-10-14
  • Publish Date: 2011-01-30
  •   Objective  To analyze the short- and long-term outcomes of surgical treatment of active infective endocarditis(IE).  Methods  Surgeries were performed for 71 patients with active IE from January 2001 to July 2010. Patients with prosthetic valve or healed IE were excluded.  Results  Of these 71 patients, the mean age was 44.6±14.4 years, and 55(77.5%) were men. Streptococcus was the most common causative microorganism. Two patients (2.8%) died during post-surgical hospital stay. Survivors were followed up for 42.4±32.4 months. The actuarial 1-, 5-, and 10-year survival rates were (98.5±1.5)%, (92.6±4.5)%, and (79.4±12.8)%, respectively.  Conclusion  Surgery can achieve satisfactory short- and long-term effectiveness for active IE.
  • loading
  • [1] Tornos P, Iung B, Permanyer-Miralda G, et al.Infective endocarditis in Europe:lessons from the Euro heart survey[J].Heart, 2005, 91:571-575. doi:  10.1136/hrt.2003.032128
    [2] Cabell CH, Abrutyn E, Fowler VG Jr, et al.International Collaboration on Endocarditis Merged Database (ICE-MD) Study Group Investigators.Use of surgery in patients with native valve infective endocarditis:results from the International Collaboration on Endocarditis Merged Database[J].Am Heart J, 2005, 150:1092-1098. doi:  10.1016/j.ahj.2005.03.057
    [3] David T, Gavra G, Feindel C, et al.Surgical treatment of active infective endocarditis:a continued challenge[J].J Thorac Cardiovasc Surg, 2007, 133:144-149. doi:  10.1016/j.jtcvs.2006.08.060
    [4] The Society of Thoracic Surgeons.STS Adultcardiac surgery database data definitions[DB/OL].[2009-01-19].http://www.sts.org/sections/stsnationaldatabase/datamanagers/adultcardiacdb/datacollection/index.html2005.
    [5] Beynon RP, Bahl VK, Prendergast BD.Infective endocarditis[J].BMJ, 2006, 333:334-339. doi:  10.1136/bmj.333.7563.334
    [6] Alexiou C, Langley SM, Stafford H, et al.Surgery for active culture-positive endocarditis:determinants of early and late outcome[J].Ann Thorac Surg, 2000, 69:1448-1454. doi:  10.1016/S0003-4975(00)01139-5
    [7] Gammie JS, O'Brien SM, Griffith BP, et al.Surgical treatment of mitral valve endocarditis in North America[J].Ann Thorac Surg, 2005, 80:2199-2204. doi:  10.1016/j.athoracsur.2005.05.036
    [8] Hill EE, Herregods MC, Vanderschueren S, et al.Outcome of patients requiring valve surgery during active infective endocarditis[J].Ann Thorac Surg, 2008, 85:1564-1570. doi:  10.1016/j.athoracsur.2008.02.014
    [9] David TE, Gavra G, Feindel CM, et al.Surgical treatment of active infective endocarditis:a continued challenge[J].J Thorac Cardiovasc Surg, 2007, 133:144-149. doi:  10.1016/j.jtcvs.2006.08.060
    [10] Ruttmann E, Legit C, Poelzl G, et al.Mitral valve repair provides improved outcome over replacement in active infective endocarditis[J].J Thorac Cardiovasc Surg, 2005, 130:765-771. doi:  10.1016/j.jtcvs.2005.03.016
    [11] Sabik JF, Lytle BW, Blackstone EH, et al.Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis[J].Ann Thorac Surg, 2002, 74:650-659. doi:  10.1016/S0003-4975(02)03779-7
    [12] Obadia JF, Henaine R, Bergerot C, et al.Monobloc aortomitral homograft or mechanical valve replacement:a new surgical option for extensive bivalvular endocarditis[J].J Thorac Cardiovasc Surg, 2006, 131:243-245. doi:  10.1016/j.jtcvs.2005.05.058
    [13] Avierinos JF, Thuny F, Chalvignac V, et al.Surgical treatment of active aortic endocarditis:homografts are not the cornerstone of outcome[J].Ann Thorac Surg, 2007, 84:1935-1942. doi:  10.1016/j.athoracsur.2007.06.050
    [14] Piper C, Wiemer M, Schulte HD, et al.Stroke is nota contraindication for urgent valve replacement in acute infective endocarditis[J].J Heart Valve Dis, 2001, 10:703-711. http://europepmc.org/abstract/MED/11767174
    [15] Gillinov AM, Shah RV, Curtis WE, et al.Valve replacement in patients with endocarditis and acute neurologic deficit[J].Ann Thorac Surg, 1996, 61:1125-1129. doi:  10.1016/0003-4975(96)00014-8
    [16] Hill EE, Hurijgers P, Herregods MC, etal.Evolving trends in infective endocarditis[J].Clin Microbiol Infect, 2006, 12:5-12. doi:  10.1111/j.1469-0691.2005.01289.x
    [17] Miro JM, Anguera I, Cabell CH, et al.Staphylococcus aureus native valve infective endocarditis:report on 566 episodes from the International Collaboration on Endocarditis[J].Clin Infect Dis, 2005, 41:507-514. doi:  10.1086/431979
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(1)

    Article Metrics

    Article views (187) PDF downloads(6) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return